Alexion Pharmaceuticals, Inc.

Connor, Clark & Lunn Investment Management Ltd. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/12/2021

Shares

9,842

Value ($000)

1,808

Weight

0.0%

2014 Q1 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/12/2021	1,808	0.0%	9,842	6/30/2021
2021 Q1	5/13/2021	1,919	0.0%	12,550	3/31/2021
2020 Q4	2/16/2021	1,868	0.0%	11,954	12/31/2020
2020 Q2	8/13/2020	981	0.0%	8,742	6/30/2020
2020 Q1	5/13/2020	11,252	0.1%	125,310	3/31/2020
2019 Q4	2/12/2020	25,817	0.2%	238,715	12/31/2019
2014 Q1	5/14/2014	345	0.0%	2,053	3/31/2014